Literature DB >> 13900292

Erythroblastosis fetalis, obstetrical management.

R C GOODLIN.   

Abstract

The anemia of erythroblastotic infants can be predicted antenatally by the indirect Coombs test, amniotic fluid pigment levels and maternal excretion of chorionic gonadotrophin. The only effective therapy for fetal anemia is delivery before the development of fetal hydrops. This may be accomplished by focusing attention on factors indicative of fetal anemia and by delivering potentially anemic fetuses as soon as they are sufficiently mature to escape the problems of prematurity.

Entities:  

Keywords:  ERYTHROBLASTOSIS, FETAL/therapy

Mesh:

Year:  1962        PMID: 13900292      PMCID: PMC1574676     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  4 in total

1.  Prognosis of fetuses at 33 weeks' gestation in Rh-sensitized women who have had preceding stillbirths.

Authors:  G BIERING; I KAISER; W KRIVIT
Journal:  J Lancet       Date:  1959-06

2.  Case for induction of labour in treatment of haemolytic disease of the newborn.

Authors:  G A KELSALL; G H VOS; R L KIRK
Journal:  Br Med J       Date:  1958-08-23

3.  The composition of liquor amnii in haemolytic disease of the newborn.

Authors:  D C A BEVIS
Journal:  J Obstet Gynaecol Br Emp       Date:  1953-04

4.  Antenatal diagnosis of the Rh erythroblastotic fetus.

Authors:  W C RIGSBY; N VORYS; W E COPELAND; J C ULLERY
Journal:  Obstet Gynecol       Date:  1961-11       Impact factor: 7.661

  4 in total
  1 in total

1.  Recent obstetrical advances in the Rh problem: antepartum management, amniocentesis, and experience with hysterotomy and surgery in utero.

Authors:  V J Freda
Journal:  Bull N Y Acad Med       Date:  1966-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.